Squarepoint
MCRB icon

Squarepoint’s Seres Therapeutics MCRB Stock Holding History

Squarepoint’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,908
Closed -$232K – 4727
2025
Q2 		$232K Buy
+20,908
New +$184K ﹤0.01% 3879
2024
Q4 		– Sell
-2,237
Closed -$42.3K – 5320
2024
Q3 		$42.3K Buy
+2,237
New +$45.4K ﹤0.01% 3990
2024
Q1 		– Sell
-5,700
Closed -$160K – 4350
2023
Q4 		$160K Buy
+5,700
New +$150K ﹤0.01% 3665
2022
Q3 		– Sell
-1,895
Closed -$130K – 3240
2022
Q2 		$130K Buy
+1,895
New +$163K ﹤0.01% 2582
2022
Q1 		– Sell
-968
Closed -$161K – 3252
2021
Q4 		$161K Buy
+968
New +$154K ﹤0.01% 2788
2021
Q3 		– Sell
-718
Closed -$342K – 3216
2021
Q2 		$342K Sell
718
-6,401
-90% -$2.7M ﹤0.01% 2427
2021
Q1 		$2.93M Buy
7,119
+33
+0.5% +$15.2K 0.02% 876
2020
Q4 		$3.47M Buy
7,086
+1,609
+29% +$942K 0.03% 644
2020
Q3 		$3.1M Sell
5,477
-454
-8% -$151K 0.04% 503
2020
Q2 		$565K Buy
5,931
+3,249
+121% +$285K 0.01% 1254
2020
Q1 		$191K Sell
2,682
-10,882
-80% -$730K ﹤0.01% 1489
2019
Q4 		$936K Buy
13,564
+10,889
+407% +$808K 0.01% 1367
2019
Q3 		$215K Buy
+2,675
New +$177K ﹤0.01% 2047
2018
Q3 		– Sell
-684
Closed -$118K – 2114
2018
Q2 		$118K Buy
+684
New +$112K ﹤0.01% 1625

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Squarepoint's MCRB Position: Q3 2025 in Review

Squarepoint sold out of Seres Therapeutics (MCRB) in Q3 2025, closing a stake of 20,908 shares — an estimated $232K sold.

Squarepoint first reported a position in MCRB in Q2 2018 and held it in 14 quarters. The position peaked at $3.47M in Q4 2020. 32 funds tracked by Wall St. Rank hold MCRB as of Q3 2025.

  • Squarepoint reported no remaining Seres Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 20,908 Seres Therapeutics shares in Q3 2025, an estimated $232K.
  • Squarepoint first reported a position in Seres Therapeutics in Q2 2018 and held it in 14 quarters.
  • Squarepoint's Seres Therapeutics position peaked at $3.47M in Q4 2020.
  • 32 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.